Study S002444

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)

Registration

Registration: NCT07703683
Acronym: SARC-ENDO
Study type: OBSERVATIONAL
Status: RECRUITING
Enrollment: 100
Start: 2026-02-19
Primary completion: 2056-12-31
Lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions: Diabetes; Obesity & Overweight; Cushing Syndrome; Metabolic Diseases; Endocrine Diseases; Sarcopenia; Sarcopenic Obesity
Interventions: DRUG:GLP-1 Receptor Agonists
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Prevalence of sarcopenia / sarcopenic obesity [From February 2026 to december 2056]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.